137 related articles for article (PubMed ID: 3324444)
41. Deregulation and overexpression of c-fos proto-oncogene in rat renal cell-lines and primary tumors induced by dimethylnitrosamine.
Shore SK; Hard GC; Magee PN
Oncogene; 1988 Nov; 3(5):567-70. PubMed ID: 3152601
[TBL] [Abstract][Full Text] [Related]
42. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus.
Weisz A; Bresciani F
Mol Endocrinol; 1988 Sep; 2(9):816-24. PubMed ID: 3173352
[TBL] [Abstract][Full Text] [Related]
43. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
44. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
45. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
Kunimi K; Uchibayashi T; Hisazumi H
Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
[TBL] [Abstract][Full Text] [Related]
46. Genotype markers and proto-oncogene analysis in the CD30-positive "malignant histiocytosis" DEL cell line with t(5;6)(q35;p21).
Gogusev J; Barbey S; Nezelof C
Int J Cancer; 1990 Jul; 46(1):106-12. PubMed ID: 2163988
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
48. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
49. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
51. Replication of proto-oncogenes early during the S phase in mammalian cell lines.
Iqbal MA; Chinsky J; Didamo V; Schildkraut CL
Nucleic Acids Res; 1987 Jan; 15(1):87-103. PubMed ID: 3469620
[TBL] [Abstract][Full Text] [Related]
52. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
[TBL] [Abstract][Full Text] [Related]
53. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
54. Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.
Pfeifer AM; Mark GE; Malan-Shibley L; Graziano S; Amstad P; Harris CC
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10075-9. PubMed ID: 2557616
[TBL] [Abstract][Full Text] [Related]
55. Estrogen-induced proto-oncogene and suppressor gene expression in the hamster kidney: significance for estrogen carcinogenesis.
Hou X; Li JJ; Chen W; Li SA
Cancer Res; 1996 Jun; 56(11):2616-20. PubMed ID: 8653706
[TBL] [Abstract][Full Text] [Related]
56. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
57. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
58. Expression of the c-rel and c-myc proto-oncogenes in avian tissues.
Moore BE; Bose HR
Oncogene; 1989 Jul; 4(7):845-52. PubMed ID: 2666905
[TBL] [Abstract][Full Text] [Related]
59. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
60. Structure and expression of oncogenes in surgical specimens of human breast carcinomas.
Biunno I; Pozzi MR; Pierotti MA; Pilotti S; Cattoretti G; Della Porta G
Br J Cancer; 1988 May; 57(5):464-8. PubMed ID: 3293644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
